With the growing popularity of GLP-1 medications such as Ozempic, Wegovy and Mounjaro, experts are warning that travellers who do not inform their insurer about their treatment could face having claims rejected, even if the claim is unrelated to their weight loss medication. The Association of British Insurers said it is vital that travellers declare any pre-existing medical conditions as well as any prescribed medication or treatment when taking out travel insurance.
A spokesperson for the ABI told The Sun: “It’s essential to declare any pre-existing medical conditions and prescribed medications or treatments when taking out travel insurance – including weight loss jabs.
“Doing so will help you get the right cover for your needs, while failing to share this information could cause issues at the point of claim or even invalidate your policy.”
If a policy is invalidated, holidaymakers may have to pay for expensive overseas medical treatment or emergency repatriation themselves, with costs potentially running into hundreds of thousands of pounds.
Several major insurers have confirmed that failing to disclose the medical condition associated with a prescription for weight-loss injections could affect coverage.
Aviva told The Sun that customers must disclose medical conditions, such as obesity, if medication has been prescribed to treat them, warning that claims related to undisclosed conditions would not be covered.
AXA and Admiral both said customers generally need to declare the underlying medical condition rather than the medication itself.
Both insurers warned that failing to disclose the condition for which the injections were prescribed could result in a claim being rejected or a reduced payout.
Staysure said it can provide cover for customers using weight-loss injections, provided they have been prescribed by a GP or registered pharmacy, form part of a recognised weight-loss programme, appear in the customer’s medical records, and their doctor confirms they are fit to travel.
However, the insurer warned that failing to declare the treatment could invalidate cover for medical claims, whether directly or indirectly linked to the medication.
This story originally appeared on Express.co.uk
